(1,3-Dioxolan-2-ylmethyl)magnesium bromide solution

MilliporeSigma Canada Ltd

Revision date : 2025-01-22

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS07 GHS02 GHS08
Health risk rating 4
Safety risk rating 5
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

109-99-9

Name of the chemical

Tetrahydrofuran (618/2012)

Concentration

<=100% 5-53

General Information

Version

8.8

Revision date

2025-01-22

Product name

(1,3-Dioxolan-2-ylmethyl)magnesium bromide solution

CAS No.

180675-22-3

REACH No

01-2119444314-46-XXXX

1.2.2. Uses advised against

For R&D use only. Not for pharmaceutical, household or other uses

Emergency telephone

+1-703-527-3887

Icons in SDS

GHS02 GHS07 GHS08

Company Information

company name

MilliporeSigma Canada Ltd

GHS Information

Signal word

Danger

Hazard Codes

Hazard statements (CLP)

H225, H302, H314, H318, H335, H336, H351

Hazard statements

Code

Statements

H225

Highly Flammable liquid and vapour

Section 2

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

Flammable liquids, (Category 2) H225: Highly flammable liquid and vapor. Acute toxicity, (Category 4) H302: Harmful if swallowed. Skin corrosion, (Sub-category H314: Causes severe skin burns and eye 1B) damage. Serious eye damage, (Category H318: Causes serious eye damage. 1) Carcinogenicity, (Category 2) H351: Suspected of causing cancer. Specific target organ toxicity - H336: May cause drowsiness or dizziness. single exposure, (Category 3), Central nervous system Specific target organ toxicity - H335: May cause respiratory irritation. single exposure, (Category 3),

Signal word

Danger Danger

Hazard statements

H225 Highly flammable liquid and vapor. H302 Harmful if swallowed. H314 Causes severe skin burns and eye damage. H335 May cause respiratory irritation. H336 May cause drowsiness or dizziness. H351 Suspected of causing cancer. H314 Causes severe skin burns and eye damage. H351 Suspected of causing cancer.

Precautionary statements

P201 Obtain special instructions before use. P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P303 + P361 + P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. P305 + P351 + P338 + IF IN EYES: Rinse cautiously with water for several minutes. P310 Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/ doctor. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P201 Obtain special instructions before use. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P303 + P361 + P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. P305 + P351 + P338 + IF IN EYES: Rinse cautiously with water for several minutes. P310 Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/ doctor. P308 + P313 IF exposed or concerned: Get medical advice/ attention.

Supplemental label elements

EUH018 In use may form flammable/explosive vapor-air mixture. EUH019 May form explosive peroxides. Reduced Labeling (<= 125 ml) EUH018 In use may form flammable/explosive vapor-air mixture. EUH019 May form explosive peroxides.

Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.